Kong Han Tan

INEX INNOVATE Pte Ltd. is a Singaporean molecular diagnostics company that specializes in women's and fetal health. The private company is based in Singapore, Singapore. The company was founded by Mahesh Choolani. Kane Black has been the CEO of the company since 2019.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

Part of Genting Bhd., DNAe Diagnostics Ltd. is a British biotechnology company founded in 2015. The private company is based in London, UK and engages in research and development on biotechnology.

Part of Genting Bhd., DNAe Group Holdings Ltd. is a healthcare company based in London, UK. DNAe is commercializing its pioneering semiconductor sequencing technology for healthcare applications, including infectious disease and cancer testing and monitoring. The British company is developing Lidia-seq™, a user-friendly, direct-from-specimen platform that performs genomic analysis on a microchip, to provide actionable information to clinicians. DNAe's initial focus is on infectious disease diagnostics, where speed and DNA-specific information can make the difference between life and death. The private company's major shareholder is Genting Berhad, a Malaysian-based investor with a growing portfolio of investments in cutting-edge life sciences companies. The company was founded in 2003 by Christofer Toumazou. The CEO is Samuel Reed.

Part of Genting Bhd., GB Services Bhd. The private company is based in Kuala Lumpur, Malaysia. provides services related to leisure, hospitality, gambling, plantation, and property sectors.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

INEX INNOVATE Pte Ltd. is a Singaporean molecular diagnostics company that specializes in women's and fetal health. The private company is based in Singapore, Singapore. The company was founded by Mahesh Choolani. Kane Black has been the CEO of the company since 2019.

CorTechs Labs, Inc. provides medical image analysis solutions. Its products include NeuroQuant, LesionQuant, PETQuanti, AutoAlign, PowerScribe Integration, and TrenWorks Analytics. The company was founded by Eric Halgren and Anders M. Dale in 1996 and is headquartered in San Diego, CA.

CorTechs Labs, Inc. provides medical image analysis solutions. Its products include NeuroQuant, LesionQuant, PETQuanti, AutoAlign, PowerScribe Integration, and TrenWorks Analytics. The company was founded by Eric Halgren and Anders M. Dale in 1996 and is headquartered in San Diego, CA.

Part of Genting Bhd., DNAe Group Holdings Ltd. is a healthcare company based in London, UK. DNAe is commercializing its pioneering semiconductor sequencing technology for healthcare applications, including infectious disease and cancer testing and monitoring. The British company is developing Lidia-seq™, a user-friendly, direct-from-specimen platform that performs genomic analysis on a microchip, to provide actionable information to clinicians. DNAe's initial focus is on infectious disease diagnostics, where speed and DNA-specific information can make the difference between life and death. The private company's major shareholder is Genting Berhad, a Malaysian-based investor with a growing portfolio of investments in cutting-edge life sciences companies. The company was founded in 2003 by Christofer Toumazou. The CEO is Samuel Reed.

CorTechs Labs, Inc. provides medical image analysis solutions. Its products include NeuroQuant, LesionQuant, PETQuanti, AutoAlign, PowerScribe Integration, and TrenWorks Analytics. The company was founded by Eric Halgren and Anders M. Dale in 1996 and is headquartered in San Diego, CA.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

Part of Olympia Industries Bhd., Pan Malaysian Pools Sdn. The private company is based in Kuala Lumpur, Malaysia. Bhd. is a Malaysian company that operates and manages horse racing businesses. Pan Malaysian Pools Sdn. from Tanjong Capital Sdn. on December 13, 2010. was acquired by Olympia Industries Bhd.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

ACGT Sdn. Bhd. develops genomics-based solutions to increase productivity from oil palm and other crops. The company is headquartered in Kuala Lumpur, Malaysia.

Part of Olympia Industries Bhd., Pan Malaysian Pools Sdn. The private company is based in Kuala Lumpur, Malaysia. Bhd. is a Malaysian company that operates and manages horse racing businesses. Pan Malaysian Pools Sdn. from Tanjong Capital Sdn. on December 13, 2010. was acquired by Olympia Industries Bhd.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

INEX INNOVATE Pte Ltd. is a Singaporean molecular diagnostics company that specializes in women's and fetal health. The private company is based in Singapore, Singapore. The company was founded by Mahesh Choolani. Kane Black has been the CEO of the company since 2019.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

Elevance Renewable Sciences, Inc. engages in the production of novel and specialty chemicals from plant oils. It offers cleaning and personal care ingredients, coating materials, oil field chemicals, surfactant intermediates, and polymer building blocks products. The company was founded in 2007 and is headquartered in Pearland, TX.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

CorTechs Labs, Inc. provides medical image analysis solutions. Its products include NeuroQuant, LesionQuant, PETQuanti, AutoAlign, PowerScribe Integration, and TrenWorks Analytics. The company was founded by Eric Halgren and Anders M. Dale in 1996 and is headquartered in San Diego, CA.

INEX INNOVATE Pte Ltd. is a Singaporean molecular diagnostics company that specializes in women's and fetal health. The private company is based in Singapore, Singapore. The company was founded by Mahesh Choolani. Kane Black has been the CEO of the company since 2019.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.